1. Animal models and treatments for addiction and depression co-morbidity

   • Neil E. Paterson
   • Athina Markou

   OriginalPaper Pages: 1 - 32

2. Pharmacotherapy for schizophrenia and co-occurring substance use disorders

   • Alan I. Green

   OriginalPaper Pages: 33 - 39

3. Modeling tardive dyskinesia: Predictive 5-HT_2C receptor antagonist treatment

   • Richard M. Kostrzewa
   • Nuo-Yu Huang
   • Ryszard Brus

   OriginalPaper Pages: 41 - 50

4. Association in alcoholic patients between Psychopathic Traits and the additive effect of allelic forms of theCNR1 andFAAH endocannabinoid genes, and the 3′ Region of theDRD2 Gene

   • Janet Hoenicka
   • Guillermo Ponce
   • Tomás Palomo

   OriginalPaper Pages: 51 - 59

5. From dopaminergic genes to psychiatric disorders

   • Janet Hoenicka
   • María aragüés
   • Tomás Palomo

   OriginalPaper Pages: 61 - 71

6. Are some genetic risk factors common to schizophrenia, bipolar disorder and depression? evidence fromDISC1, GRIK4 andNRG1

   • Douglas H. R. Blackwood
   • Ben J. Pickard
   • Walter J. Muir

   OriginalPaper Pages: 73 - 83